Curative by Design™
Gumireddy K. et al. (2015) AKAP4 is a circulating biomarker for non-small cell lung cancer. Oncotarget 6:1.
Li H.-M. et al. (2015) Expression and clinical significance of A-kinase anchor protein 4 in lung adenocarcinoma tissue. Thoracic Cancer 7:271.
Saini S. et al. (2013) A Novel Cancer Testis Antigen, A-Kinase Anchor Protein 4 (AKAP4) Is a Potential Biomarker for Breast Cancer. PLoS ONE 8(2):e57095.
Agarwal S. et al. (2013) The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma OncoImmunology 2(5):e24270.
Jagadish N. et al. (2016) A novel cancer testis antigen target A-kinase anchor protein (AKAP4) for the early diagnosis and immunotherapy of colon cancer. OncoImmunology 5(2); e1078965.
Robinson D. et al. (2015) Integrative Clinical Genomics of Advanced Prostate Cancer, Cell 161:1215.
The Cancer Genome Atlas Research Network (2015) The Molecular Taxonomy of Primary Prostate Cancer. Cell 163:1011.
Bayliss R. et al. (2016) Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs. Cell Mol Life Sci 73:1209.
French C., (2014) NUT midline carcinoma. Nat Rev Cancer 14:149.
Stathis A, et al. (2016) Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibito OTX015/MK-8628 Cancer Discovery 6:1.
Kong H. et al. (2012) The Regulatory Mechanism of the LY6K Gene Expression in Human Breast Cancer Cells. J Biol Chem 287:38889.